SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022697
Filing Date
2022-11-07
Accepted
2022-11-07 17:01:21
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20220930.htm   iXBRL 10-Q 2630033
2 EX-10.1 hcwb-ex10_1.htm EX-10.1 235195
3 EX-10.2 hcwb-ex10_2.htm EX-10.2 296322
4 EX-31.1 hcwb-ex31_1.htm EX-31.1 17839
5 EX-31.2 hcwb-ex31_2.htm EX-31.2 18010
6 EX-32.1 hcwb-ex32_1.htm EX-32.1 13529
7 EX-32.2 hcwb-ex32_2.htm EX-32.2 13179
  Complete submission text file 0000950170-22-022697.txt   6729014

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220930_lab.xml EX-101.LAB 266461
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220930_pre.xml EX-101.PRE 196078
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220930.xsd EX-101.SCH 28953
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hcwb-20220930_def.xml EX-101.DEF 132798
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hcwb-20220930_cal.xml EX-101.CAL 28527
44 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220930_htm.xml XML 749368
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 221366289
SIC: 2834 Pharmaceutical Preparations